PRELUDE CAPITAL MANAGEMENT, LLC - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q4 2019$3,000
-40.0%
6,3980.0%0.00%
Q3 2019$5,000
-98.3%
6,398
-90.5%
0.00%
-100.0%
Q2 2019$291,000
-72.4%
67,046
-53.4%
0.01%
-76.3%
Q1 2019$1,054,000
-5.0%
143,747
-2.4%
0.06%
-21.3%
Q4 2018$1,110,000147,2470.08%
Other shareholders

There were no reported owners of INTEC PHARMA LTD JERUSALEM in Q1 2019.

NameSharesValueWeighting ↓
View complete list of INTEC PHARMA LTD JERUSALEM shareholders